Cases 1 - 2 of 2
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
as 2:2014md02510
Counter Defendant:
Invitae Corporation, Myriad Genetics, Quest Diagnostics and others
Counter Claimant:
Pathway Genomics and Ambry Genetics
Undetermined:
Labroratory Corporation of America Holdings, AARP, GeneDX and others
In Re:
BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
Cause Of Action: 35 U.S.C. § 0271
Kings English, The et al v. Shurtleff et al
as 2:2005cv00485
Plaintiff:
Kings English, The, Kings English, The, Kings English, The and others
Defendant:
Mark Shurtleff, Mark Shurtleff, Von J. Christiansen and others
Cause Of Action: 42 U.S.C. § 1983 Civil Rights Act
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
